PB0742 JAK2 V617F Allele Burden and Thrombotic Events in Patients with JAK2 V617F Positive Polycythemia Vera or Essential Thrombocythemia at High Risk of Thrombosis

Conclusion(s): This data indicates platelets undergo changes after the first dose of chemotherapy.In order to observe the impact in each cancer type and cancer progression, long term follow up are required.These follow up studies can help understand how platelets can be targeted to improve outcomes and therapies in those patients.